Results of allogeneic bone marrow transplants for leukemia using donors other than HLA-identical siblings

Journal of Clinical Oncology

Volumn 15, Issue 5, 1997, Pages 1767-1777

  Szydlo, R ^a   Goldman, J M ^a   Klein, J P ^a   Gale, R P ^a   Ash, R C ^a   Bach, F H ^a   Bradley, B A ^a   Casper, J T ^a   Flomenberg, N ^a   Gajewski, J L ^a   Gluckman, E ^a   Henslee Downey, P J ^a   Hows, J M ^a   Jacobsen, N ^a   Kolb, H J ^a   Lowenberg, B ^a   Masaoka, T ^a   Rowlings, P A ^a   Sondel, P M ^a   van Bekkum, D W ^a   van Rood, J J ^a   Vowels, M R ^a   Zhang, M J ^a   Horowitz, M M ^a   more..

^a MEDICAL COLLEGE OF WISCONSIN   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HLA A ANTIGEN; HLA ANTIGEN; HLA B ANTIGEN; HLA DR ANTIGEN;

ACUTE GRANULOCYTIC LEUKEMIA; ACUTE LYMPHOBLASTIC LEUKEMIA; ADOLESCENT; ADULT; ALLOGENIC BONE MARROW TRANSPLANTATION; ARTICLE; CANCER SURVIVAL; CHILD; CHRONIC MYELOID LEUKEMIA; GRAFT FAILURE; GRAFT VERSUS HOST REACTION; HISTOCOMPATIBILITY; HLA MATCHING; HUMAN; MAJOR CLINICAL STUDY; ORGAN DONOR; PRIORITY JOURNAL;

EID: 0030965047     PISSN: 0732183X     EISSN: None     Source Type: Journal    
DOI: 10.1200/JCO.1997.15.5.1767     Document Type: Article

References (46)

1. Westoff CF: Fertility in the United States. Science 234:544-549, 1986
2. Vowels MR, Honeyman M, Ziegler J, et al: Searches for matched and closely matched related and unrelated marrow donors undertaken in a paediatric unit. J Pediatr Child Health 28:379-382, 1992
3. Beatty PG, Dahlberg S, Mickelson EM, et al: Probability of finding HLA-matched unrelated marrow donors. Transplantation 45:714-718, 1988.
4. Powles RL, Kay HEM, Clink HM, et al: Mismatched family donors for bone marrow transplantation as treatment for acute leukaemia. Lancet 1:612-615, 1983
5. Filopovich AH, Ramsay NKC, McGlave PB, et al: Mismatched bone marrow transplantation at the University of Minnesota: Use of related donors other than HLA MLC identical siblings and T cell depletion, in Gale RP (ed): Recent Advances in Bone Marrow Transplantation. New York, NY, Alan R. Liss, 1983, pp 769-783
6. Beatty PG, Clift RA, Mickelson EM, et al: Marrow transplantation from related donors other than HLA-identical siblings. N Engl J Med 313:765-771, 1985
7. Filopovich AH, Ramsay NKC, Arthur DC, et al: Allogeneic bone marrow transplantation with related donors other than HLA MLC-matched siblings, and the use of antithymocyte globulin, prednisone, and methotrexate for prophylaxis of graft-versus-host disease. Transplantation 39:282-285, 1985
8. O'Reilly RJ, Brochstein J, Collins N, et al: Evaluation of HLA-haplotype disparate parental marrow grafts depleted of T-lymphocytes by differential agglutination with a soybean lectin and E-rosette depletion for the treatment of severe combined immunodeficiency. Vox Sang 51:81-86, 1986 (suppl 2)
9. Beatty PG, Di Bartolomeo P, Storb R, et al: Treatment of aplastic anemia with marrow grafts from related donors other than HLA genotypically matched siblings. Clin Transplant 1:117-124, 1987
10. Beatty PG, Anasetti C, Thomas ED, et al: Marrow transplantation from relatives other than HLA-identical siblings, in Gale RP, Champlin RE (eds): Bone Marrow Transplantation: Current Controversies. New York, NY, Alan R. Liss, 1989, pp 619-624
11. Camitta B, Ash RA, Menitove J, et al: Bone marrow transplantation for children with severe aplastic anemia: Use of donors other than HLA-identical siblings. Blood 74:1852-1857, 1989
12. Anasetti C, Amos D, Beatty PG, et al: Effect of HLA compatibility on engraftment of bone marrow transplants in patients with leukemia or lymphoma. N Engl J Med 320:197-204, 1989
13. Ash RC, Horowitz MM, Gale RP, et al: Bone marrow transplantation from related donors other than HLA-identical siblings: Effect of T-cell depletion. Bone Marrow Transplant 7:443-452, 1991
14. Horowitz SD, Groshong T, Bach FH, et al: Treatment of severe combined immunodeficiency with bone marrow from an unrelated, mixed-leucocyte-culture-non-reactive donor. Lancet 2:431-433, 1975
15. O'Reilly RJ, Dupont B, Pahwa S, et al: Reconstitution in severe combined immunodeficiency by transplantation of marrow from an unrelated donor. N Engl J Med 297:1311-1318, 1977
16. Hansen JA, Clift RA, Thomas ED, et al: Transplantation of marrow from an unrelated donor to a patient with acute leukemia. N Engl J Med 303:565-567, 1980
17. Gordon-Smith EC, Fairhead SM, Chipping PM, et al: Bone-marrow transplantation for severe aplastic anaemia using histocompatible unrelated volunteer donors. Br Med J 285:835-837, 1982
18. Gingrich RD, Howes CWS, Goeken NE, et al: The use of partially matched, unrelated donors in clinical bone marrow transplantation. Transplantation 39:526-532, 1985
19. Hows JM, Yin JL, Marsh J, et al: Histocompatible unrelated volunteer donors compared with HLA nonidentical family donors in marrow transplantation for aplastic anemia and leukemia. Blood 68:1322-1328, 1986
20. McGlave P, Scott E, Ramsay N, et al: Unrelated donor bone marrow transplantation therapy for chronic myelogenous leukemia. Blood 70:877-881, 1987
21. Beatty PG, Ash R, Hows JM, et al: The use of unrelated bone marrow donors in the treatment of patients with chronic myelogenous leukemia: Experience of four marrow transplant centers. Bone Marrow Transplant 4:287-290, 1989
22. Hows J, Mackinnon, Brookes P, et al: Matched unrelated donor transplantation. Transplant Proc 21:2923-2925, 1989
23. Beatty PG, Hansen JA, Anasetti C, et al: Marrow transplantation from unrelated volunteer donors. Transplant Proc 21:2993-2994, 1989
24. Gingrich RD, Ginder GD, Goeken NE, et al: Allogeneic marrow grafting with partially mismatched, unrelated marrow donors. Blood 71:1375-1381, 1988
25. Ash RC, Casper JT, Chitambar C, et al: Successful allogeneic marrow transplantation from closely HLA-matched unrelated donors using T-cell depletion. N Engl J Med 322:485-494, 1990
26. Kernan NA, Bartsch G, Ash RC, et al: Analysis of 462 transplantations from unrelated donors facilitated by the National Marrow Donor Program. N Engl J Med 328:593-602, 1993
27. Marks DI, Cullis JO, Ward KN, et al: Allogeneic bone marrow transplantation for chronic myeloid leukemia using sibling and volunteer unrelated donors: A comparison of complications in the first 2 years. Ann Intern Med 119:207-214, 1993
28. Davies SM, Shu XO, Blazar BR, et al: Unrelated donor bone marrow transplanation: Influence of HLA A and B incompatibility on outcome. Blood 86:1636-1642, 1995
29. Casper J, Camitta B, Truitt R, et al: Unrelated bone marrow donor transplants for children with leukemia or myelodysplasia. Blood 85:2354-2363, 1995
30. Petersdorf EW, Longton GM, Anasetti C, et al: The significance of HLA-DRB1 matching on clinical outcome after HLA-A, B DR identical unrelated donor marrow transplantation. Blood 86:1606-1613, 1995
31. Spencer A, Szydlo RM, Brookes PA, et al: Bone marrow transplantation for chronic myeloid leukemia with volunteer unrelated donors using ex vivo or in vivo t-cell depletion: Major prognostic impact of HLA class I identity between donor and recipient. Blood 86:3590-3597, 1995
32. Schiller G, Feig SA, Territo M, et al: Treatment of advanced leukaemia with allogeneic bone marrow transplantation from unrelated donors. Br J Haematol 88:72-78, 1994
33. Henslee-Downey PJ, Parrish RS, Macdonald JS, et al: Combined in vitro and in vivo T lymphocyte depletion for the control of graft-versus-host disease following haploidentical marrow transplant. Transplantation 61:738-745, 1996
34. Fleming DR, Henslee-Downey PJ, Romond EH, et al: Success of allogeneic bone marrow transplantation with partially mismatched related donors for advanced acute lymphoblastic leukemia. Bone Marrow Transplant 17:917-922, 1996
35. Henslee-Downey PJ: Mismatched bone marrow transplantation. Curr Opin Oncol 7:115-121, 1995
36. Godder K, Pati A, Abhyankar S, et al: Partially mismatched related donor transplants as salvage therapy for patients with refractory leukemia who relapse post-BMT. Bone Marrow Transplant 17:49-53, 1996
37. Ringdén O. Horowitz MM, Sondel P, et al: Methotrexate, cyclosporine, or both to prevent graft-versus-host disease after HLA-identical sibling bone marrow transplants for early leukemia? Blood 81:1094-1101, 1993
38. Champlin RE, Horowitz MM, van Bekkum DW, et al: Graft failure following bone marrow transplantation for severe aplastic anemia. Risk factors and treatment results. Blood 73:606-613, 1989
39. Gale RP, Bortin MM, van Bekkum DW, et al: Risk factors for acute graft-versus-host disease. Br J Haematol 67:397-406, 1987
40. Atkinson K, Horowitz MM, Gale RP, et al: Risk factors for acute graft-vs-host disease after HLA-identical sibling bone marrow transplantation. Blood 75:2459-2464, 1990
41. Cox DR: Regression models and life-tables. J R Stat Soc (B) 34:187-202, 1972
42. Horowitz MM, Bortin MM: The role of registries in evaluating the results of bone marrow transplantation, in Treleaven J, Barrett J (eds): Bone Marrow Transplantation in Practice. Edinburgh, United Kingdom, Churchill Livingstone, 1992, pp 367-377
43. United States General Accounting Office Report to the Ranking Minority Member; Subcommittee on Health, Committee on Ways and Means, House of Representatives: Bone marrow transplantation: International comparisons of availability and appropriateness of use. Washington, DC, March, 1994
44. Passweg JR, Champlin RE, Klein JP, et al: Comparison of techniques for T-cell depletion: Effects on leukemia-free survival. Blood 84:539a, 1994 (abstr 2142: suppl 1)
45. Petersdorf EW, Smith AG, Mickelson EM, et al: Ten HLA-DR4 alleles defined by sequence polymorphisms within the DRB1 first domain. Immunogenetics 33:267-275, 1991
46. Hansen JA, Gooley T, Clift R, et al: Unrelated donor marrow transplants for patients with chronic myeloid leukemia. Blood 86:123a, 1995 (abstr 479; suppl 1)